跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CAFFEINE CITRATE ORAL SOLUTION USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CAFFEINE CITRATE ORAL SOLUTION USP
Authorized
STANDARD
CAFFEINE CITRATE ORAL SOLUTION USP
omega laboratories limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
ae55f7e2e1af8226
Company
omega laboratories limited
Type
Standard
Approval Details
Approval Id
ae55f7e2e1af8226
Drug Approval Canada Name
CAFFEINE CITRATE ORAL SOLUTION USP
Product Name
CAFFEINE CITRATE ORAL SOLUTION USP
Status
Marketed
Status Date
2023-07-11
Original Market Date
2023-07-11
Din
02526751
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:20.32
Atc Original
N06BC01 CAFFEINE
Atc Name
n 06 bc 01
Aig Number
0162054001
Company Name
omega laboratories limited
Company Address
11177 Hamon, Montreal, Quebec, Canada, H3M 3E4
Active Ingredients
CAFFEINE CITRATE
20 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
ae55f7e2e1af8226
Type
Standard
Back to Health Canada Approvals